{"status":"OK","data":{"advertisement":{"id":354312,"title":"Zapytanie ofertowe nr KPOT/5/PR144029/2026-3084-268587 na zakup us\u0142ugi przeprowadzenia bada\u0144 por\u00f3wnawczych aktywno\u015bci biologicznej formulacji farmaceutycznych wg opracowanych metod.","partial_offer_allowed":false,"publication_date":"2026-03-11","submission_deadline":"2026-03-23 23:59:59","planned_sign_date":"2026-03-01","supplementary_orders":null,"terms_of_contract_change":"Szczeg\u00f3\u0142y w za\u0142\u0105czniku \"Zapytanie ofertowe nr KPOT/5/PR144029/2026-3084-268587\" paragraf XIII.","created_at":"2026-03-11 10:58:58","modified_at":"2026-03-24 00:00:27","contact_persons":[{"id":5781,"forename":"Pawe\u0142","surname":"Brzezi\u0144ski","phone_number":"","email":"pawel.brzezinski@polpharma.com","created_by":null,"created_at":"2026-06-22 12:46:12","modified_at":"2026-06-22 12:46:12","modified_by":null}],"orders":[{"id":573169,"estimated_value":null,"order_items":[{"id":645541,"description":"Post\u0119powanie jest prowadzone w zwi\u0105zku z realizacj\u0105 przedsi\u0119wzi\u0119cia pod nazw\u0105 \u201eOpracowanie i rozw\u00f3j iniekcyjnego leku generycznego opartego na substancji aktywnej z grupy polipeptyd\u00f3w w terapii cukrzycy typu 2\u201d w ramach Krajowego Planu Odbudowy i Zwi\u0119kszenia Odporno\u015bci, Komponentu D \u201eEfektywno\u015b\u0107, dost\u0119pno\u015b\u0107 i jako\u015b\u0107 systemu ochrony zdrowia\u201d, Inwestycja D3.1.1 \u201eKompleksowy rozw\u00f3j bada\u0144 w zakresie nauk medycznych i nauk o zdrowiu\u201d.\nPrzedmiotem zam\u00f3wienia jest zakup us\u0142ugi przeprowadzenia bada\u0144 por\u00f3wnawczych aktywno\u015bci biologicznej formulacji farmaceutycznych wg opracowanych metod, szczeg\u00f3\u0142y w za\u0142\u0105czniku \"Zapytanie ofertowe nr KPOT/5/PR144029/2026-3084-268587\".\n\nPe\u0142ne i szczeg\u00f3\u0142owe informacje dotycz\u0105ce zam\u00f3wienia (w tym: opis przedmiotu zam\u00f3wienia, termin realizacji zam\u00f3wienia, warunki udzia\u0142u w post\u0119powaniu i podstawy wykluczenia, opis sposobu obliczania ceny, opis kryteri\u00f3w, kt\u00f3rymi zamawiaj\u0105cy b\u0119dzie si\u0119 kierowa\u0142 przy wyborze oferty,\nmiejsce oraz termin sk\u0142adania i otwarcia ofert, opis sposobu przygotowania oferty, spos\u00f3b porozumiewania si\u0119 zamawiaj\u0105cego z wykonawcami, osoby upowa\u017cnione do kontaktu, tryb oceny ofert i og\u0142oszenia wynik\u00f3w, zmiana tre\u015bci umowy, pozosta\u0142e informacje) znajduj\u0105 si\u0119 w Za\u0142\u0105czniku \"Zapytanie ofertowe KPOT/5/PR144029/2026-3084-268587\"","warranty_period":null,"cpv_items":[{"id":8512,"code":"73000000-2","name":"Us\u0142ugi badawcze i eksperymentalno-rozwojowe oraz pokrewne us\u0142ugi doradcze"}],"timetable_items":[],"fulfillment_places":[{"country":"Polska","voivodeship":null,"poviat":null,"commune":null,"locality":null,"created_by":null,"created_at":"2026-03-11 10:58:58","modified_at":"2026-03-11 12:20:15","modified_by":null,"id":733785,"type":{"id":2,"name":"ca\u0142a Polska"},"group_uuid":"b41bce34-3752-4a44-a731-3f913321792c"}],"participation_conditions":[{"id":1837477,"description":"Zamawiaj\u0105cy uzna, \u017ce Oferent spe\u0142nia niniejszy warunek, je\u017celi z\u0142o\u017cy o\u015bwiadczenie, \u017ce dysponuje uprawnieniami niezb\u0119dnymi do prawid\u0142owej realizacji zam\u00f3wienia, w tym uprawnieniami w zakresie prowadzenia test\u00f3w aktywno\u015bci dla substancji z wykorzystaniem technik luminescencji.","type":{"id":1,"name":"Uprawnienia do wykonywania okre\u015blonej dzia\u0142alno\u015bci lub czynno\u015bci"},"created_by":null,"created_at":"2026-03-11 10:58:58","modified_at":"2026-03-11 12:20:15","modified_by":null,"group_uuid":"d265e4fd-134e-4aef-894d-ea3c76964823"},{"id":1837478,"description":"Zamawiaj\u0105cy uzna, \u017ce Oferent spe\u0142nia niniejszy warunek, je\u017celi z\u0142o\u017cy o\u015bwiadczenie, \u017ce dysponuje wiedz\u0105 i do\u015bwiadczeniem niezb\u0119dnymi do prawid\u0142owej realizacji zam\u00f3wienia, w tym posiada wiedz\u0119 i dysponuje co najmniej 5-letnim do\u015bwiadczeniem w wykonywaniu prac badawczych w obszarze biologii molekularnej w tym w zakresie bada\u0144 aktywno\u015bci biologicznej substancji/produkt\u00f3w.","type":{"id":2,"name":"Wiedza i do\u015bwiadczenie"},"created_by":null,"created_at":"2026-03-11 10:58:58","modified_at":"2026-03-11 12:20:15","modified_by":null,"group_uuid":"ac7e0e21-7560-4cff-a311-9ad3cef29129"},{"id":1837479,"description":"Zamawiaj\u0105cy uzna, \u017ce Oferent spe\u0142nia niniejszy warunek udzia\u0142u w post\u0119powaniu, je\u017celi z\u0142o\u017cy o\u015bwiadczenie o dysponowaniu zapleczem technicznym niezb\u0119dnym do prawid\u0142owej realizacji zam\u00f3wienia, w tym przedstawi dokument potwierdzaj\u0105cy zezwolenie na prowadzenie laboratorium drugiego poziomu bezpiecze\u0144stwa (BSL 2) przeznaczonego do pracy z GMM II, w formie \u201eDecyzji\u201d wydawanej przez Ministra Klimatu i \u015arodowiska.","type":{"id":3,"name":"Potencja\u0142 techniczny"},"created_by":null,"created_at":"2026-03-11 10:58:58","modified_at":"2026-03-11 12:20:15","modified_by":null,"group_uuid":"3908ff20-f190-450f-a593-ebf8d4c4a9f1"},{"id":1837480,"description":"Zamawiaj\u0105cy uzna, \u017ce Oferent spe\u0142nia niniejszy warunek, je\u017celi z\u0142o\u017cy o\u015bwiadczenie, \u017ce dysponuje zasobami ludzkimi odpowiednio wykfalifikowanymi, niezb\u0119dnymi do prawid\u0142owej realizacji zam\u00f3wienia.","type":{"id":4,"name":"Osoby zdolne do wykonania zam\u00f3wienia"},"created_by":null,"created_at":"2026-03-11 10:58:58","modified_at":"2026-03-11 12:20:15","modified_by":null,"group_uuid":"43b6c65c-ead9-4dd7-bf04-4a28cfe1c9a2"},{"id":1837481,"description":"Zamawiaj\u0105cy uzna, \u017ce Oferent spe\u0142nia niniejszy warunek, je\u017celi z\u0142o\u017cy o\u015bwiadczenie, \u017ce znajduje si\u0119 w sytuacji ekonomicznej i finansowej zapewniaj\u0105cej prawid\u0142ow\u0105 realizacj\u0119 zam\u00f3wienia, \nw szczeg\u00f3lno\u015bci nie znajduje si\u0119 w stanie upad\u0142o\u015bci, restrukturyzacji lub likwidacji.","type":{"id":5,"name":"Sytuacja ekonomiczna i finansowa"},"created_by":null,"created_at":"2026-03-11 10:58:58","modified_at":"2026-03-11 12:20:15","modified_by":null,"group_uuid":"77de1540-53c6-4c7c-8737-086043315875"}],"category":{"id":1,"name":"Us\u0142uga"},"subcategory":{"id":4,"name":"Us\u0142ugi badawcze"},"created_by":null,"created_at":"2026-03-11 10:58:58","modified_at":"2026-03-11 12:20:15","modified_by":null,"group_uuid":"3f963508-bdc4-4eb2-aec0-b1de178def4c"}],"evaluation_criteria":[{"id":1030578,"price_criterion":true,"description":"Liczba punkt\u00f3w (PC) w kryterium \u201eCena\u201d obliczana b\u0119dzie wed\u0142ug wzoru:\nPc=Cn/Cb *100 \ngdzie:\nPC\t\tliczba punkt\u00f3w ramach kryterium \u201eCena\u201d\nCN\t\tspo\u015br\u00f3d ofert nieodrzuconych najni\u017csza cena netto \nCB\t\tcena netto badanej oferty","created_by":null,"created_at":"2026-03-11 11:04:51","modified_at":"2026-03-11 12:20:15","modified_by":null,"group_uuid":"564c949c-3a08-4770-809d-d0ebda904377"}],"is_variant":false,"title":"Badania por\u00f3wnawcze aktywno\u015bci biologicznej","order_node":{"id":433548},"created_by":null,"created_at":"2026-03-11 10:58:58","modified_at":"2026-03-11 12:20:15","modified_by":null}],"created_by":{"id":3084,"contact_persons":[]},"modified_by":{"modified_by":null,"id":1,"contact_persons":[]},"status":{"id":2,"label":"PUBLISHED","name":"Opublikowane"},"advertiser_address_details":{"name":"Zak\u0142ady Farmaceutyczne Polpharma SA","identification_number_type":"nip","identification_number":"5920202822","address":{"country":"Polska","voivodeship":"pomorskie","poviat":"starogardzki","commune":"Starogard Gda\u0144ski","locality":"Starogard Gda\u0144ski","created_by":null,"created_at":null,"modified_at":null,"modified_by":null,"id":996621,"street":"Pelpli\u0144ska","number_description":"19","postcode":"83-200"},"created_by":{"id":3084,"contact_persons":[]},"created_at":"2026-03-11 10:58:55","modified_at":"2026-03-11 10:58:55","modified_by":{"id":3084,"contact_persons":[]},"id":355278},"advertisement":{"id":268587,"number":"2026-3084-268587","publication_date":"2026-03-11","created_by":{"id":3084,"contact_persons":[]},"created_at":"2026-03-11 10:58:55","modified_at":"2026-03-24 00:00:27","modified_by":{"modified_by":null,"id":1,"contact_persons":[]},"status":{"id":6,"label":"RESOLVED","name":"Rozstrzygni\u0119te"},"all_available_version_ids":[354312],"enrollment":null,"projects":[{"id":61385,"name":"Opracowanie i rozw\u00f3j iniekcyjnego leku generycznego opartego na substancji aktywnej z grupy polipeptyd\u00f3w w terapii cukrzycy typu 2.","number":"0003/24","activity":{"created_by":{"id":114,"contact_persons":[{"id":43,"forename":"Anna","surname":"Nowak","phone_number":"111222333","email":"anna@email.com","created_at":"2026-08-26 10:58:57","modified_at":"2026-08-26 10:58:57"}]},"created_at":"2025-02-21 07:12:20","modified_at":"2025-02-21 07:12:20","modified_by":{"id":114,"contact_persons":[{"id":43,"forename":"Anna","surname":"Nowak","phone_number":"111222333","email":"anna@email.com","created_at":"2026-08-26 10:58:57","modified_at":"2026-08-26 10:58:57"}]}},"region":null,"institution":{"created_by":{"id":114,"contact_persons":[{"id":43,"forename":"Anna","surname":"Nowak","phone_number":"111222333","email":"anna@email.com","created_at":"2026-08-26 10:58:57","modified_at":"2026-08-26 10:58:57"}]},"created_at":"2025-02-21 08:20:32","modified_at":"2025-02-21 08:20:32","modified_by":{"id":114,"contact_persons":[{"id":43,"forename":"Anna","surname":"Nowak","phone_number":"111222333","email":"anna@email.com","created_at":"2026-08-26 10:58:57","modified_at":"2026-08-26 10:58:57"}]}},"full_number":"KPOD.07.07-IW.07-0003/24","perspective":{},"programme":{"created_by":{"modified_by":null,"id":89,"contact_persons":[]},"created_at":"2023-05-25 08:16:12","modified_at":"2023-05-25 08:16:12","modified_by":{"modified_by":null,"id":89,"contact_persons":[]}},"priority":{"created_by":{"id":114,"contact_persons":[{"id":43,"forename":"Anna","surname":"Nowak","phone_number":"111222333","email":"anna@email.com","created_at":"2026-08-26 10:58:57","modified_at":"2026-08-26 10:58:57"}]},"created_at":"2025-02-20 10:10:06","modified_at":"2025-02-20 10:10:06","modified_by":{"id":114,"contact_persons":[{"id":43,"forename":"Anna","surname":"Nowak","phone_number":"111222333","email":"anna@email.com","created_at":"2026-08-26 10:58:57","modified_at":"2026-08-26 10:58:57"}]}},"type":"project","created_by":{"id":3084,"contact_persons":[]},"created_at":"2025-06-17 11:06:30","modified_at":"2025-06-17 11:06:30","modified_by":{"id":3084,"contact_persons":[]}}],"is_author":false,"is_admin":false},"attachments":[{"origin":{"id":354312,"publication_date":"2026-03-11"},"id":2385441,"name":"ZA\u0141\u0104CZNIK NR 4 RODO.pdf","file":{"id":2649255,"name":"ZA\u0141\u0104CZNIK NR 4 RODO.pdf","created_at":"2026-03-11 12:15:03","created_by":{"forename":"Pawe\u0142","surname":"Brzezi\u0144ski"},"uri":"/api/files/2649255"},"group_uuid":"0ca9d6d9-0662-4ecc-ab92-8f59f75babb8"},{"origin":{"id":354312,"publication_date":"2026-03-11"},"id":2385442,"name":"ZA\u0141\u0104CZNIK NR 3 NDA.docx","file":{"id":2649256,"name":"ZA\u0141\u0104CZNIK NR 3 NDA.docx","created_at":"2026-03-11 12:15:10","created_by":{"forename":"Pawe\u0142","surname":"Brzezi\u0144ski"},"uri":"/api/files/2649256"},"group_uuid":"26239740-c876-4bfa-be9e-3d095193d8f7"},{"origin":{"id":354312,"publication_date":"2026-03-11"},"id":2385443,"name":"Zapytanie ofertowe nr KPOT_5_PR144029_2026-3084-268587.pdf","file":{"id":2649258,"name":"Zapytanie ofertowe nr KPOT_5_PR144029_2026-3084-268587.pdf","created_at":"2026-03-11 12:15:44","created_by":{"forename":"Pawe\u0142","surname":"Brzezi\u0144ski"},"uri":"/api/files/2649258"},"group_uuid":"5109a0ea-91be-4703-83fd-b6a56b701bee"}]},"dictionaries":{"announcement_status_draft":1,"announcement_status_published":2},"favorite":null,"badge":null,"offer_set_badge_count":null,"question_badge_count":null}}